Search prescribing guidance
Prescribing guidance and pathways for healthcare professionals across NHS Central East ICB.
-
Acamprosate
Acamprosate is a medicine used to support people with alcohol dependence in maintaining abstinence by helping to reduce cravings for alcohol. This page provides information on the prescribing, monitoring and ongoing management of acamprosate treatment.
-
Alemtuzumab
Alemtuzumab is a treatment used for relapsing-remitting multiple sclerosis (MS). This page provides information to support the safe use, monitoring and ongoing management of alemtuzumab therapy.
-
Amiodarone
Amiodarone is a medicine used to treat and prevent a range of abnormal heart rhythms (arrhythmias). This page provides information to support the safe prescribing, monitoring and ongoing management of amiodarone therapy, including important safety considerations and recommended monitoring requirements.
-
Anti-depressants
Antidepressants are medicines used to treat depression, anxiety disorders and a range of other mental health conditions. This page provides information to support the safe and effective use of antidepressant medicines, including treatment considerations, monitoring requirements and ongoing patient care.
-
Anticoagulation
Anticoagulant medicines are used to prevent and treat blood clots and reduce the risk of stroke, deep vein thrombosis and pulmonary embolism. This page brings together resources to support the safe and effective use of anticoagulant therapy.
-
Antimicrobial Prescribing
Antimicrobial medicines are used to prevent and treat bacterial and other infections. This page provides information to support antimicrobial stewardship, appropriate prescribing and the management of common infections.
-
Antipsychotics
Antipsychotic medicines are used to treat a range of mental health conditions, including psychosis, schizophrenia and bipolar disorder. This page provides information to support the safe and effective use of antipsychotic medicines, including prescribing considerations, monitoring requirements and ongoing patient care.
-
Apomorphine
Apomorphine is a treatment used to help manage motor fluctuations and periods of reduced mobility in people with Parkinson’s disease. This page provides information to support the safe use, monitoring and ongoing management of apomorphine therapy.
-
Asthma
Asthma is a long-term respiratory condition characterised by inflammation and narrowing of the airways. This page provides information to support the diagnosis, treatment and ongoing management of asthma in adults and children, helping to optimise symptom control and reduce the risk of exacerbations.
-
Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy
A range of medicines are used in the management of attention deficit hyperactivity disorder (ADHD) and narcolepsy. Some medicines may be used for both conditions. This page provides information on the safe and effective use of these medicines, including prescribing considerations, monitoring requirements and ongoing patient care.
-
Bladder and Continence Care
Bladder and continence care supports the assessment and management of urinary and bowel conditions, including urinary incontinence and other continence problems. This page provides clinical guidance, pathways, prescribing information and formularies relating to bladder and continence care.
-
Bosentan
Bosentan is used in the management of digital ulcers associated with systemic sclerosis and other specialist conditions. This page provides information to support the safe use, monitoring and ongoing management of bosentan therapy.
-
Cannabis-based medicinal products
Cannabis-based medicinal products are medicines derived from cannabis that may be used for certain specialist indications, including severe epilepsy, multiple sclerosis-related spasticity, and persistent chemotherapy-induced nausea and vomiting. This page provides information on their recommended use, prescribing responsibilities and place in treatment.
-
Chronic Kidney Disease
Chronic kidney disease (CKD) is a long-term condition in which kidney function gradually declines over time. This page provides information to support the identification, management and monitoring of CKD in line with best clinical practice.
-
Chronic Obstructive Pulmonary Disease (COPD)
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition characterised by airflow limitation and breathing difficulties. This page provides information to support the diagnosis, treatment and ongoing management of COPD.
-
Cinacalcet
Cinacalcet is used in the management of hyperparathyroidism and disorders of calcium and phosphate balance. This page provides information to support the safe prescribing, monitoring and ongoing management of cinacalcet therapy.
-
Commercial Medicines Schemes
Commercial medicines schemes are arrangements that support access to medicines while helping to maximise value from NHS resources. This page provides information on locally managed commercial and rebate arrangements.
-
COVID-19 Medicines
COVID-19 treatments may be available for eligible patients at increased risk of severe illness. This page provides information on patient eligibility, referral pathways and treatment options in line with current guidance.
-
Dementia
Dementia is a group of progressive conditions that affect memory, thinking, behaviour and everyday functioning. This page provides information on the treatment and ongoing management of people living with dementia.
-
Denosumab
Denosumab is used to help reduce fracture risk in people with osteoporosis and other bone disorders. This page provides information on the safe use and ongoing management of denosumab treatment.